Publications by authors named "Samuel Borgert"

Claim this Profile
E
Evaluation of Susceptibility Patterns in Uropathogens and Empiric Antibiotic Therapy in the Emergency Department.
Mira Koro, Samuel Borgert, Andrew Abbott, Veena Venugopalan

Hosp Pharm· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SCAN: A novel approach for vancomycin time-out.
Kayihura Manigaba, Samuel J Borgert, Kenneth P Klinker, Kartikeya Cherabuddi, Veena Venugopalan

Infect Control Hosp Epidemiol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing antimicrobial stewardship initiatives: Clinical evaluation of cefepime or piperacillin/tazobactam in patients with bloodstream infections secondary to AmpC-producing organisms.
Lacie McKamey, Veena Venugopalan, Kartikeya Cherabuddi, Samuel Borgert, Stacy Voils

Int J Antimicrob Agents· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Training a Drug to Do New Tricks: Insights on Stability of Meropenem Administered as a Continuous Infusion.
Veena Venugopalan, Kayihura Manigaba, Samuel J Borgert, Jessica Cope, Charles A Peloquin

Microbiol Insights· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ampicillin for the treatment of complicated urinary tract infections caused by vancomycin-resistant Enterococcus spp (VRE): a single-center university hospital experience.
Kairav J Shah, Kartikeya Cherabuddi, Joseph Shultz, Samuel Borgert, Reuben Ramphal

Int J Antimicrob Agents· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the CYP2C19 genotype on voriconazole exposure in adults with invasive fungal infections.
Issam S Hamadeh, Kenneth P Klinker, Samuel J Borgert, Ashley I Richards, Wenhui Li

Pharmacogenet Genomics· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and economic impact of antimicrobial stewardship interventions with the FilmArray blood culture identification panel.
Joe Pardo, Kenneth P Klinker, Samuel J Borgert, Brittany M Butler, Patricia G Giglio

Diagn Microbiol Infect Dis· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moving Closer to Zero: Effect of "Just in Time" Dosing of Prophylactic Antibiotics on Surgical Site Infections.
Joe Pardo, Kenneth P Klinker, Barbara Swift, Samuel J Borgert, Nikolaus Gravenstein

Hosp Pharm· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond Vancomycin: The Tail of the Lipoglycopeptides.
Kenneth P Klinker, Samuel J Borgert

Clin Ther· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of Neisseria meningitidis from negative blood cultures and cerebrospinal fluid with the FilmArray blood culture identification panel.
Joe Pardo, Kenneth P Klinker, Samuel J Borgert, Brittany M Butler, Kenneth H Rand

J Clin Microbiol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to positivity of blood cultures supports antibiotic de-escalation at 48 hours.
Joe Pardo, Kenneth P Klinker, Samuel J Borgert, Gaurav Trikha, Kenneth H Rand

Ann Pharmacother· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring quality metrics to identify and monitor antimicrobial stewardship program quality improvement efforts.
David J Guervil, Kenneth P Klinker, Nicole T Reardon, Hassan M Alnuaimat, Samuel J Borgert

Infect Control Hosp Epidemiol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis